🕵️ Pacira Biosciences, Inc. ($PCRX)
SEC insider & ownership activity, last 12 months · CIK 1396814 · every row links its SEC filing
Over the last 12 months insiders sold $2.5M with no open-market buying against it. Cross Shawn sold $1.5M through a program of 7 sale notices averaging $217K (Nov–Apr). DOMA Perpetual Capital Management LLC added 5.7% → 6.9%. No red-flag 8-Ks in the window.
🚨 5 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 5 sellers, $2.5M (16 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Cross Shawn | 0 | – | 7 | $1.5M | Apr 23, 2026 |
| Williams Kristen | 0 | – | 2 | $498K | Jun 4, 2026 |
| Riker Lauren | 0 | – | 3 | $261K | Jun 11, 2026 |
| Slonin Jonathan | 0 | – | 3 | $240K | Aug 17, 2026 |
| Froimson Mark | 0 | – | 1 | $11K | Mar 17, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15.2% | 13G | Apr 28, 2025 | filing ↗ | |
| Pedro Escudero | 7.3% | 13D | Mar 11, 2026 | filing ↗ | |
| DOMA1 LLC | 6.9% | 13D | Mar 11, 2026 | filing ↗ | |
| DOMA Perpetual Capital Management LLC | 6.9% | 13D | Mar 11, 2026 | filing ↗ | |
| DOMA Perpetual Partners GP LLC | 6.8% | 13D | Dec 30, 2025 | filing ↗ | |
| Vanguard Portfolio Management | 6.4% | 13G | May 1, 2026 | filing ↗ | |
| State Street Corporation | 5.2% | 13G | Aug 7, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | May 1, 2026 | filing ↗ | |
| Dimensional Fund Advisors LP | 5.1% | 13G | Apr 9, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Slonin Jonathan | $71K | Aug 17, 2026 | filing ↗ |
| Ceesay Abraham | $210K | Jun 12, 2026 | filing ↗ |
| Riker Lauren | $144K | Jun 11, 2026 | filing ↗ |
| Williams Kristen | $228K | Jun 4, 2026 | filing ↗ |
| Cross Shawn | $326K | Apr 23, 2026 | filing ↗ |
| Cross Shawn | $38K | Apr 22, 2026 | filing ↗ |
| Cross Shawn | $71K | Apr 21, 2026 | filing ↗ |
| Cross Shawn | $194K | Apr 20, 2026 | filing ↗ |
| Froimson Mark | $11K | Mar 17, 2026 | filing ↗ |
| Slonin Jonathan | $74K | Mar 17, 2026 | filing ↗ |
| Riker Lauren | $84K | Feb 2, 2026 | filing ↗ |
| Williams Kristen | $270K | Feb 2, 2026 | filing ↗ |
| Riker Lauren | $34K | Jan 5, 2026 | filing ↗ |
| Cross Shawn | $229K | Dec 10, 2025 | filing ↗ |
| Cross Shawn | $398K | Dec 9, 2025 | filing ↗ |
| Slonin Jonathan | $95K | Nov 17, 2025 | filing ↗ |
| Cross Shawn | $266K | Nov 10, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 9, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 9, 2026 | filing ↗ |
| Other events (8.01) | Jun 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 9, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 27, 2026 | filing ↗ |
| Earnings (2.02) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |